Literature DB >> 11171608

Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anemia.

M S Buchowski1, F A de la Fuente, P J Flakoll, K Y Chen, E A Turner.   

Abstract

Contribution of bone turnover to the hypercatabolic state observed in sickle cell anemia is unknown. We examined the association between markers of bone turnover and basal rates of whole body protein turnover and energy expenditure in 28 adolescents with homozygous sickle cell anemia (HbSS) and in 26 matched controls with normal phenotype (HbAA). Whole body protein breakdown and synthesis were measured using a stable isotope of [15N]glycine, resting energy expenditure was measured by whole room indirect calorimetry, and the rate of pyridinoline cross-link (PYD) excretion in urine and fasting serum levels of the type I procollagen carboxy-terminal propeptide (PICP) were measured with commercial kits. Urinary PYD and serum PICP were significantly elevated in HbSS patients. The increase in procollagen synthesis, indicated by high levels of PICP, was significantly correlated with increased whole body protein synthesis. The increase in type I collagen degradation, indicated by high PYD excretion, was significantly correlated with increased protein breakdown. We conclude that increased rates of bone turnover contribute to the increased rates of protein turnover and energy expenditure observed in adolescents with homozygous sickle cell anemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171608     DOI: 10.1152/ajpendo.2001.280.3.E518

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  8 in total

1.  Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia.

Authors:  Ellen B Fung; Deborah A Kawchak; Babette S Zemel; Alisha J Rovner; Kwaku Ohene-Frempong; Virginia A Stallings
Journal:  Pediatr Blood Cancer       Date:  2008-03       Impact factor: 3.167

2.  Biochemical indicator of sickle cell disease: preliminary report from India.

Authors:  S Pandey; A Sharma; S Dahia; V Shah; V Sharma; R M Mishra; Sw Pandey; R Saxena
Journal:  Indian J Clin Biochem       Date:  2011-09-25

3.  Attenuated maximal muscle strength and peak power in children with sickle cell disease.

Authors:  Kelly A Dougherty; Joan I Schall; Alisha J Rovner; Virginia A Stallings; Babette S Zemel
Journal:  J Pediatr Hematol Oncol       Date:  2011-03       Impact factor: 1.289

4.  Malnutrition in Sickle Cell Anemia: Implications for Infection, Growth, and Maturation.

Authors:  Hyacinth I Hyacinth; Oluwatoyosi A Adekeye; Christopher S Yilgwan
Journal:  J Soc Behav Health Sci       Date:  2013-01-01

5.  Predictors of osteoclast activity in patients with sickle cell disease.

Authors:  Mehdi Nouraie; Kevin Cheng; Xiaomei Niu; Evadne Moore-King; Margaret F Fadojutimi-Akinsi; Caterina P Minniti; Craig Sable; Sohail Rana; Niti Dham; Andrew Campbell; Gregory Ensing; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

6.  Calcium homeostasis may influence resting energy expenditure with effects most apparent in early pubertal girls.

Authors:  L J Hanks; K Casazza; A Ashraf; J R Fernandez
Journal:  Acta Paediatr       Date:  2012-05-16       Impact factor: 2.299

7.  The association of bone mineral density and parathyroid hormone with serum magnesium in adult patients with sickle-cell anaemia.

Authors:  Mohamed F Elshal; Amna E Bernawi; Maryam A Al-Ghamdy; Jalaluddin A Jalal
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

8.  Normal muscle oxygen consumption and fatigability in sickle cell patients despite reduced microvascular oxygenation and hemorheological abnormalities.

Authors:  Xavier Waltz; Aurélien Pichon; Nathalie Lemonne; Danièle Mougenel; Marie-Laure Lalanne-Mistrih; Yann Lamarre; Vanessa Tarer; Benoit Tressières; Maryse Etienne-Julan; Marie-Dominique Hardy-Dessources; Olivier Hue; Philippe Connes
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.